Isabel Kalofonos insider trades

Open-market stock purchases and sales by Isabel Kalofonos, Chief Commercial Officer at CG Oncology, Inc, from SEC Form 4 filings since Apr 28, 2023.

Recent trades

DateStockTradeValue
Oct 15, 2026CGON CG Oncology, IncBought (not open market)—
Sep 1, 2026CRNX Crinetics Pharmaceuticals, IncSold (not open market)$142K
Sep 1, 2026CRNX Crinetics Pharmaceuticals, IncSold (not open market)$2.9M
Sep 1, 2026CRNX Crinetics Pharmaceuticals, IncSold (not open market)$4.3M
Sep 1, 2026CRNX Crinetics Pharmaceuticals, IncSold (not open market)$2.3M
Feb 23, 2026CRNX Crinetics Pharmaceuticals, IncBought (not open market)—
Feb 23, 2026CRNX Crinetics Pharmaceuticals, IncBought (not open market)—
Jan 5, 2026CRNX Crinetics Pharmaceuticals, IncSold$138K
Jan 5, 2026CRNX Crinetics Pharmaceuticals, IncBought (not open market)—

Companies traded

  • CGON CG Oncology, Inc: other filings, last Oct 15, 2026
  • CRNX Crinetics Pharmaceuticals, Inc: 1 sale, last Sep 1, 2026
  • IMGN ImmunoGen, Inc: other filings, last Feb 12, 2024

Get free alerts when Isabel Kalofonos files a new trade →